The effect of pericapsular nerve group block and lateral femoral cutaneous nerve block on postoperative recovery after hip arthroplasty.
Yuan Tian, Qianqian Lu, Yuxin Yuan...
https://pubmed.ncbi.nlm.nih.gov/40481108/Actively Recruiting
Led by Huazhong University of Science and Technology · Updated on 2026-09-29
136
Participants Needed
1
Research Sites
1 weeks
Total Duration
Researchers are evaluating two different nerve block techniques to manage pain after total hip arthroplasty THA, a common surgery to replace damaged hip joints. The study compares the newer QLESP block, which targets two areas with one injection, to the currently used PENG block combined with the LFCN block. The trial aims to find which method better controls pain and reduces opioid use within the first 24 hours after surgery, while also assessing leg movement recovery, walking time, hospital stay length, and side effects. Participants will be randomly assigned to receive either the QLESP block or the PENGLFCN block after surgery. The QLESP block involves a single-puncture, dual-plane injection of 30 mL of 0.375% ropivacaine, while the PENGLFCN block combines two injections totaling the same ropivacaine dose. All participants undergo standardized general anesthesia and postoperative multimodal pain treatment. Additionally, a subgroup will provide blood samples before surgery and 24 hours after to explore molecular differences in pain response. During the study, participants will be followed for 48 hours after surgery with evaluations including pain scores at multiple time points, opioid use, motor block assessments, time to first walking, hospital stay duration, and side effect monitoring. The primary measure is opioid consumption within 24 hours post-surgery. Safety and functional recovery outcomes will also be tracked. The total participation duration covers the immediate postoperative period up to two days.
CONDITIONS
QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty
X
Xi Wu
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Huazhong University of Science and Technology
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 48 hours after surgery
Participants receive either the QLESP block or the PENG combined with LFCN block after surgery, along with standard general anesthesia and postoperative pain management.
Assessments at 6, 12, 24, 36, and 48 hours post-surgery
Duration - 48 hours post-surgery
Researchers monitor pain scores, opioid use, leg movement, time to first walk, hospital stay length, and any side effects during the 48-hour postoperative period.
Multiple assessments during follow-up period
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yuan Tian, Qianqian Lu, Yuxin Yuan...
https://pubmed.ncbi.nlm.nih.gov/40481108/Ellen Hay, Tara Kelly, Bethany J Wolf...
https://pubmed.ncbi.nlm.nih.gov/39389587/Francesco Vetrone, Stefano Marelli, Andrea Galimberti...
https://pubmed.ncbi.nlm.nih.gov/40559093/Giuseppe Pascarella, Fabio Costa, Alessandro Strumia...
https://pubmed.ncbi.nlm.nih.gov/38731203/Fan Yang, Qiang Tang, Bing Wang...
https://pubmed.ncbi.nlm.nih.gov/41601711/Ludan Liang, Can Zhang, Wei Dai...
https://pubmed.ncbi.nlm.nih.gov/37043081/Huazhong University of Science and Technology
Lead Sponsor